Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ...
Stereotaxis (STXS) and CardioFocus announced they have entered into a Collaboration Agreement to advance robotic Pulsed Field Ablation, PFA, ...
As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today announced the first series of patients treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback